Skip to main navigation Skip to search Skip to main content

Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective

  • Jean-Michel Hannoun-Levi*
  • , Julie Margenthaler
  • , Bethany Anderson
  • , Rosa Di Micco
  • , Douglas Arthur
  • , Marianne Aznar
  • , Mary Pat Berry
  • , Thelma Brown
  • , Erin Burke
  • , Jana De Boniface
  • , Jill Dietz
  • , David Dodwell
  • , Irma Fredriksson
  • , Oreste Davide Gentilini
  • , Benjamin Guix
  • , Cristina Gutierrez
  • , Renate Haidinger
  • , Diane Heditsian
  • , Ashutosh Kothari
  • , Barbara Lestage
  • Janice Lyons, Yvonne Florence Mclean, Mairead Mackenzie, Icro Meattini, Angel Montero-Luis, Firas Mourtada, Toan Nguyen, Lori Petitti, Csaba Polgar, Philip Poortmans, Nicola Rocco, Helena Sackey, Terry Sarantou, Shayna Showalter, Vratislav Strnad, Thorsten Kuehn, Jose Volders, Marie-Jeanne Vrancken Peeters, Catheryn Yashar, Isabel T. Rubio, Jessica Gahm, Youssef Zeidan, Orit Kaidar-Person, Frederick M. Dirbas
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Background: In case of a second ipsilateral breast cancer event (2ndiBCE) after primary breast conserving treatment (BCT), patients are offered salvage mastectomy (SM) or, for selected patients, 2ndBCT. An international survey dedicated to breast cancer survivors investigated patients' preferences and expectations. Methods: An international survey was drafted jointly with breast cancer patient advocates from the United States (n = 6) and Europe (n = 2). The survey was validated with 33 questions divided into four themes: demographic data, oncological outcomes, patient views and financial issues. The survey was sent to breast cancer survivors. All information provided was anonymized. Results: From 06/24 to 10/24, 105 patients answered the online survey. The common patient profile was a white (76 %), married (61.5 %), Christian (58.8 %), US-resident (70.2 %) woman aged between 61 and 70 (62.2 %). Long-term outcomes were perceived as being well established for SM (51.5 %) and 2ndBCT (17.1 %). Breast re-irradiation was considered at risk of complications (65.7 %), and 63 % of the patients thought that 2ndBCT provides a more acceptable body self-image. 2ndBCT was expected to give superior cosmetic outcomes than SM with breast reconstruction (55.4 %). Having enough information and ample time to consider the pros and cons of treatment options were very important/important for 99 % and 96.2 %, respectively. Treatment choice was not influenced by financial concerns for 68.3 %. Conclusion: Patient perspective is very important in the decision-making process regarding salvage treatments. Physicians must provide clear, timely information which will enable patients to choose the treatment that best meets their expectations.
Original languageEnglish
Article number110484
Number of pages7
JournalEuropean Journal of Surgical Oncology
Volume51
Issue number12
Early online date1 Nov 2025
DOIs
Publication statusPublished - 1 Dec 2025

Keywords

  • Breast cancer
  • Ipsilateral breast cancer recurrence
  • Mastectomy
  • 2nd breast conserving treatment
  • Re-irradiation
  • SENTINEL NODE BIOPSY
  • 20-YEAR FOLLOW-UP
  • CONSERVATIVE TREATMENT
  • TUMOR EVENT
  • MASTECTOMY
  • RECURRENCE
  • SURGERY

Fingerprint

Dive into the research topics of 'Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective'. Together they form a unique fingerprint.

Cite this